IIARD International Institute of Academic Research and Development

INTERNATIONAL JOURNAL OF MEDICAL EVALUATION AND PHYSICAL REPORT (IJMEPR )

E-ISSN 2579-0498
P-ISSN 2695-2181
VOL. 8 NO. 4 2024
DOI: https://doi.org/10.56201/ijmepr.v8.no4.2024.pg55.62

---

The Role of Hormonal Therapy for Premenopausal Women, With Early Stages Hormone Receptor Positive Breast Cancer

Dr. Ali K. Shaaeli, Dr. Alaa Sadeq Alawad, Dr. Heider Kereem Ameen

---

Abstract

To highlight Tamoxifen and ovarian suppression as effective adjuvant approaches for premenopausal steroid receptor-positive breast cancer. In addition to encourage surgeons toward breast-conserving surgery with this effective adjuvant approaches.

keywords:

Brest cancer, Tamoxifen, Goserelin

---

References:

Bardou V-J, Arpino G, Elledge RM, Osborne CK, Clark GM. Progesterone receptor status
significantly improves outcome prediction over estrogen receptor status alone for adjuvant
endocrine therapy in two large breast cancer databases. Journal of Clinical Oncology.
2003;21(10):1973-9.

2. Jones
N.L
JH,
L.
CURRENT OBSTETRIC
AND
GYNECOLOGIC
DIAGNOSIS&TREATMENT. 9 ed2003 2003. 1018-40 p.

3. Hunt K.K NLA, copeland E.m, Bland
K.I Schwart's principles of surgery. 9 ed. NewYork: McGraw-Hill; 2010. 423-74 p.

DOWNLOAD PDF

---

Back